Participants 113 171 3
operable breast cancer with 0 to 3 positive axillary nodes
Participants 545 567 4
operable breast cancer
Participants 590 737 8
Women with invasive breast cancer were eligible if there were one to three positive lymph nodes or if the node-negative tumor was greater than 1 cm
Participants 753 784 5
randomly assigned after surgery
Participants 967 1053 5
patients with estrogen receptor (ER) and/or progesterone receptor (PR)-positive tumors
Participants 1074 1106 6
2,882 eligible patients enrolled
